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Abstract  
Objectives 
In 2016 NHS England published the commissioning policy on Bone Conducting Hearing Devices 
(BCHDs). This policy was informed by updated evidence on the clinical and cost effectiveness of 
BCHDs as well as by the 2013 Bone Anchored Hearing Aid (BAHA) policy. Commissioning policies set 
the criteria for service delivery and therefore have a major impact on the care received by patients. 
It is important that stakeholders have a good appreciation of the available evidence informing policy, 
since this will promote engagement both with the policy as well as with future research leading on 
from the policy. In this paper, we provide stakeholders with a transparent and pragmatic assessment 
of the quality of the body of evidence available to inform current BCHD national policy. 
 
Method  
1) A systematic review of the literature on BCHDs published since the development of the 2013 
policy was performed in September 2016, adhering to PRISMA recommendations. The search terms 
used were: bone conduction; bone conducting; bone anchor; BAHA; Bone Anchored Hearing Aid; 
Bone Conducting Hearing Device; BCHD; Bone Conduction Hearing Implant; BCHI; Sophono; 
Bonebridge; Soundbite; Ponto; Hearing aid; implant; device; hearing device. Publications that could 
inform current BCHD policy were included. The quality of included articles was assessed using the 
Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. 
2) The quality of evidence referenced by the 2013 BAHA policy was assessed using the GRADE 
system.  
 
Results  
1) Out of the 2576 publications on BCHDs identified by the systematic search, 39 met the inclusion 
criteria for further analysis. Using the GRADE criteria, the quality of evidence was classified as of 
‘very low quality.’  
2) The 2013 BAHA policy was informed by 14 references. The GRADE system classifies the quality of 
evidence that informed the policy as of ‘very low quality’.  
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Conclusions 
The GRADE system defines the body of evidence available to inform current national BCHD policy as 
of ‘very low quality’. There is an urgent need for high quality research to help make informed policy 
decisions about the care of patients with hearing loss. An (inter)national registry of BCHDs could 
address this need. 
 
Introduction 
 
NHS England issues commissioning policies that aim to ensure that the NHS delivers better 
outcomes for patients within its available resources.1 Commissioning policies set the criteria for 
service delivery and therefore have a major impact on the care received by patients. It is important 
for commissioning policies to be based on strong evidence so that policy decisions are well 
informed. It is equally important that stakeholders have a good appreciation of the available 
evidence, since this will promote engagement both with the policy as well as with future research 
leading on from the policy. 
 
In July 2016 NHS England published the commissioning policy on Bone Conduction Hearing Implants 
(BCHI) with separate commissioning criteria for Bone Conducting Hearing Devices (BCHDs) and 
Middle Ear Implants.2 Their policy criteria for BCHDs were informed by updated evidence on the 
clinical and cost effectiveness of these devices,2 as well as by the 2013 Bone Anchored Hearing Aid 
(BAHA) commissioning policy.3 In this paper, we provide stakeholders with a transparent and 
pragmatic assessment of the quality of the body evidence available to inform current BCHD policy. 
 
Method 
 
This study was conducted in two parts: 1) Systematic review and critical assessment of the body of 
literature on BCHDs; and 2) Critical assessment of the evidence informing the 2013 BAHA policy. 
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1) A systematic review of the literature on BCHDs published since 2012, i.e. the year of the search for 
the 2013 policy, was performed adhering to the Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses (PRISMA) recommendations.4 An expert librarian designed and conducted a 
comprehensive search of the Medline and Embase databases on 15th September 2016 using the Ovid 
portal and taking into account the specific questions and types of BCHDs discussed in the 2016 
policy. The search terms used were: bone conduction; bone conducting; bone anchor; BAHA; Bone 
Anchored Hearing Aid; Bone Conducting Hearing Device; BCHD; Bone Conduction Hearing Implant; 
BCHI; Sophono; Bonebridge; Soundbite; Ponto; Hearing aid; implant; device; hearing device. 
 
Two authors (R.M and N.H), working independently, screened all titles and abstracts for eligibility; 
and records considered potentially relevant were retrieved in full text and assessed for eligibility. 
Reference lists of review articles were also screened to identify additional relevant articles. Any 
disagreements were discussed with the senior author (A.S) and resolved by consensus. Data were 
extracted independently by the same authors (R.M and N.H) and disagreements were resolved by 
discussion and consensus.  
 
Original research articles and review articles that could inform current BCHD policy were included. 
Specifically, articles were included if they covered: 
 
 Clinical and/or cost effectiveness  
 Clinical indications in adults and/or children 
 Contraindications in adult and/or children 
 Indications for bilateral vs unilateral implantation in adults and/or children 
 Additional considerations for implantation in children  
 Strategies for service provisioning 
 
Papers were excluded if they were:  
 Non-clinical research  
 Non-English language 
 Conference proceedings  
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 Letters to journal editor 
 Published before 2012 
 
The quality of included evidence was subsequently assessed using the Grading of 
Recommendations Assessment, Development, and Evaluation (GRADE) system.5 GRADE is a 
systematic and explicit approach to making judgements about the quality of evidence; and 
is widely accepted as the most effective method of linking evidence-quality evaluations to 
clinical recommendations.6 GRADE rates evidence across studies and classifies quality of 
evidence (also known as certainty in the evidence) into high, moderate, low, and very low.5 
Evidence can start high or low and move up or down based on study characteristics. 
Evidence from randomised controlled trials (RCTs) start as high-quality evidence but must 
meet certain criteria to stay at that level whilst evidence from observational studies start as 
low quality evidence but may move up in certain circumstances. The factors that increase or 
decrease quality of evidence include: quality of methodology, consistency of results across 
studies, directness (generalisability) and effect size.5  
 
2) The articles referenced by the 2013 NHS commissioning policy were obtained. The quality of this 
body of evidence was assessed using the GRADE system as above.5  
 
Results 
 
1) The systematic search revealed 3753 publications, removing duplicates left 2576 publications for 
screening of title and abstract. One hundred and four articles were full text assessed and 39 articles 
fulfilled the criteria for inclusion. Figure 1 shows the PRISMA flow chart 1.  
Table 1 summarises the 39 included articles and their critical assessment. Table 2 provides the 
GRADE assessment across this evidence. Eighteen articles were retrospective case series; 3 were 
case reports; 8 were prospective case series; 4 were systematic reviews; 4 were narrative reviews; 1 
was a Delphi study, 1 was a consensus document. All were non-RCTs and therefore started with a 
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‘low quality’ rating. Further assessment of study quality, consistency, directness and effect size, 
classified the evidence they generated as of ‘very low quality’.  
 
2) Table 3 summarises the evidence informing the 2013 commissioning policy and their critical 
assessment. Table 4 provides the GRADE assessment across this evidence. Of the 15 references 
cited,3 one was not used to inform the policy, rather it was a fact sheet on BAHAs.7 The referenced 
articles were published between 1996 and 2011 and included personal communications with 
stakeholders, advice from specialist units, original journal articles, technology assessments, a 
specialised services definitions set, a statement paper and a quality standards guideline. All 
references were non-RCTs and therefore started with a ‘low quality’ rating. Further assessment of 
study quality, consistency, directness and effect size classified the body of evidence they generated 
as of ‘very low quality’. 
 
Discussion  
 
Our work suggests that the evidence available to inform current BCHD policy is incomplete and 
needs to be strengthened, as is the case for other hearing loss management strategies.3,8-11  
 
On a European level, concerns over the evidence base for surgical implants in general has been 
raised by the IDEAL collaborative and the House of Commons Science and Technology 
committee.12,13 Across the UK and EU, implants can enter surgical practice on the basis of 
equivalence data, meaning that an implant can be used on the basis of similarity to another implant 
rather than evidence of its own safety and effectiveness.12,13 The recall of Poly Implant Prosthese 
(PIP) breast implants and metal on metal hip implants identify the dangers of relying on such data 
for the evaluation of safety and efficacy.14-16 
 
Whilst there is a clear need to strengthen the evidence base for BCHDs and other surgical implants, 
it is important to consider the barriers to high quality research and in particular to RCTs in this field. 
These relate to resource limitations, equipoise, challenges in patient recruitment, generalisability 
and loss to long term follow up.12 Some of these barriers may be overcome by the establishment of 
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an (inter)national registry of BCHDs. Compared to trials, a registry requires fewer resources, has 
stronger external validity and allows for data collection on long-term outcomes, which is particularly 
relevant to implants.17 With current initiatives to collect data on BCHDs being fragmented and 
incomplete,18,19 an (inter)national registry would provide valuable information on clinical and cost-
effectiveness that is essential for policy and guideline development.8-10,20,21,22 
 
We acknowledge that the quality assessment of evidence using GRADE involves some degree of 
arbitrariness; however advantages of its simplicity and transparency outweigh these limitations.23 
Recognising that the 2016 BCHD commissioning policy was informed by updated evidence on BCHDs 
as well as by the 2013 BAHA policy, we systematically reviewed and quality assessed the recent 
literature on BCHDs, and critically assessed the evidence informing the 2013 policy. This approach 
assures a robust assessment of the available body of evidence to inform current BCHD policy. 
 
Conclusion: 
 
Using the GRADE system, the body of evidence available to inform current national BCHD policy is 
classified as of ‘very low quality’. There is an urgent need for high quality research to help make 
informed policy decisions about the care of patients with hearing loss. An (inter)national registry of 
BCHDs could address this need.  
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Author Title Year Aim of paper Study design Factors which lower quality Factors which 
raise quality 
Summary of findings 
Gerdes et al  Comparison of Audiological Results Between a 
Transcutaneous and a Percutaneous Bone Conduction 
Instrument in Conductive Hearing Loss 
2016 To compare the hearing performance and 
QOL outcomes of the Bonebridge 
transcutaneous bone conduction implant to 
the percutaneous BAHA device  
Retrospective case 
series 
Retrospective, subjective QOL 
assessment, small sample size of 
20 patients (10 in each group) 
Presence of a 
control group  
The transcutaneous bone conduction 
hearing implant is an audiologically 
equivalent alternative to percutaneous 
bone-anchored devices in patients with 
conductive hearing loss  
 
 
Sprinzl and 
Wolf-Magele 
The Bonebridge Bone Conduction Hearing Implant: 
indication criteria, surgery and a systematic review of the 
literature 
 
2016 To assess the safety and effectiveness of 
the Bonebridge for individuals with 
conductive or mixed hearing loss, and 
single sided deafness  
 
Systematic review  Study selection, data extraction and 
study quality assessment were 
carried out by a single reviewer, 
majority of included studies were 
case series with limited sample 
sizes 
 
Systematic 
review  
The transcutaneous Bonebridge 
provides audiological benefit to patients 
suffering from conductive or mixed 
hearing loss and single sided deafness. 
It has a lower complication rate to 
percutaneous systems and higher and 
more reliable hearing gain compared to 
other transcutaneous or percutaneous 
systems  
Carr et al  Bone-conduction hearing aids in an elderly population: 
complications and quality of life assessment 
2016 To determine whether an elderly 
population with hearing impairment can be 
adequately rehabilitated with a bone 
conduction hearing aid (BAHA) 
Retrospective review Retrospective, telephone and postal 
questionnaire, large range of follow 
up times, risk of recall bias 
Sample size of 
51 patients 
The bone conduction hearing aids are 
an ideal method of hearing 
rehabilitation in the elderly for all forms 
of hearing loss. It provides significant 
benefit with no increased complication 
rate 
Crowson and 
Tucci  
Mini Review of the Cost-Effectiveness of Unilateral 
Osseointegrated Implants in Adults: Possibly Cost-
Effective for the Correct Indication 
2016 To review all cost effectiveness analyses 
on osseointegrated implants  
Narrative review   Not a systematic review Nil There are 2 cost-effectiveness 
analyses published to date. The cost-
effectiveness of the BAHA, compared 
to conventional hearing aid devices 
remains unclear. The BAHA should not 
be considered as an alternative to a 
normal hearing aid, but rather as an 
effective option for the patient given the 
correct indication 
 
Bianchin et al   Active Bone Conduction System: Outcomes with the 
Bonebridge Transcutaneous Device 
2015 To report a case series of 4 patients with 
Bonebridge implantation  
Retrospective case 
series    
Four patient case series, different 
surgical approaches used, large 
range in follow up 
Nil The Bonebridge appears to be safe 
and effective for individuals with 
chronic otitis media, aural atresia and 
otosclerosis with inadequate benefit 
from conventional surgery or bone 
conduction hearing aids 
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Iseri et al   Transcutaneous Bone-anchored Hearing Aids Versus 
Percutaneous Ones: Multicenter Comparative Clinical 
Study 
 
2015 To compare the clinical and audiological 
outcomes as well as patient satisfaction 
between the percutaneous Dermalock and 
the transcutaneous Attract systems  
Retrospective case 
series    
Retrospective study, unequal group 
sizes 
Multicentre 
study 
Both transcutaneous and percutaneous 
techniques are effective in the 
rehabilitation of conductive hearing loss 
when conventional hearing aids cannot 
be used. Better hearing results were 
observed in the percutaneous, bone-
conduction group 
 
Zernotti and 
Sarasty  
Active Bone Conduction Prosthesis: BonebridgeTM 
 
 
2015 To systematically review the surgical 
techniques and outcomes of the 
Bonebridge  
Systematic review  Systematic review not performed as 
per PRISMA guidance, poor quality 
of included studies, 20 patients 
included across all included studies 
Nil Bonebridge appears to be effective for 
patients with conductive/mixed hearing 
loss and single sided deafness. 
Bonebridge has fewer complications 
than percutaneous bone conduction 
implants and shows proven benefits in 
speech discrimination and functional 
gain 
Gavilan et al   Quality standards for bone conduction implants 
 
 
2015 To establish consensus on the quality 
standards required for centres willing to 
create a bone conduction implant program 
(transcutaneous)  
 
Quality standards 
established by the 
HEARRING network  
 
Based on expert opinion. No 
published formal methodology to 
achieve consensus 
Nil Bone conduction implants are useful in 
patients with conductive and mixed 
hearing loss for whom conventional 
surgery or hearing aids are no longer 
an option. They can also be used in 
patients affected by single-sided 
deafness  
Gurgel et al   A Novel Intraoral Bone Conduction Hearing Prosthesis: 
One-Year Safety and Efficacy Study  
 
2015 To assess the safety and efficacy of the 
SoundBite device after 12 months of use 
 
Prospective cohort 
study  
 
No randomisation, patients received 
a fee for completing questionnaires, 
subjective questionnaire, 37 patient 
loss to follow up  
Multisite, 
prospective 
cohort study, 
large sample 
size 
The SoundBite is a safe and effective 
alternative to percutaneous 
osseointegrated hearing implants for 
patients with single sided deafness 
Laske et al   Functional Results and Subjective Benefit of a 
Transcutaneous Bone Conduction Device in Patients With 
Single-Sided Deafness 
2015 To assess the Bonebridge device in adults 
with single-sided deafness 
Prospective cohort 
study 
Small sample size of 9 patients, 
subjective hearing questionnaires, 
different aetiologies of hearing loss  
Prospective 
cohort study 
Speech discrimination in noise for 
patients implanted with the Bonebridge 
is comparable with patients with other 
bone conduction hearing aids. QOL 
improved for patients. The Bonebridge 
is an effective option for patients with 
single sided deafness  
Denoyelle et al   Hearing rehabilitation with the closed skin bone-anchored 
implant Sophono Alpha1: results of a prospective study in 
15 children with ear atresia 
 
2015 To assess the effectiveness of the 
Sophono Alpha1 implant for unilateral 
hearing rehabilitation in children with ear 
atresia, compared to a BAHA on a test 
band 
Prospective case 
series 
Small sample size of 15 children, 
subjective parental reported quality 
of life, large range of follow up  
Prospective 
study 
The Sophono Alpha1 device should be 
a treatment option for children with ear 
atresia 
Leterme et al   Contralateral Routing of Signal (CROS) Hearing Aid 
versus Transcutaneous Bone Conduction in Single-Sided 
Deafness 
2015 To assess the Sophono transcutaneous 
bone conduction device in single sided 
deafness, in comparison to a CROS 
hearing aid in terms of hearing 
Prospective cross over 
study   
Small sample size of 18 patients, 
devices used for different durations 
(60 days CROS, 7 days Sophono), 
Multicentre, 
prospective 
study 
Both devices improved hearing in noise 
and the quality of life equally. 
Transcutaneous devices represent an 
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 performances, user satisfaction, and 
quality of life 
subjective QOL measure effective option in SSD 
Reinfeldt et al   The bone conduction implant: Clinical results of the first 
six patients 
 
2015 To investigate audiological and quality of 
life outcomes for a new active 
transcutaneous device called the Bone 
Conduction Implant 
 
Prospective case 
series    
Small sample size of 6 patients, 
large age range of patients, 
subjective QOL measure, 6 month 
follow up  
Prospective 
study 
The transcutaneous Bone Conduction 
Implant provides safe and significant 
hearing rehabilitation for patients with 
mild-to-moderate conductive or mixed 
hearing loss 
Briggs et al   Clinical Performance of a New Magnetic Bone Conduction 
Hearing Implant System: Results From a Prospective, 
Multicenter, Clinical Investigation  
 
 
2015 To assess the clinical performance of the 
BAHA attract system 
Prospective case 
series    
Small sample size of 27 patients Multicentre, 
prospective 
study 
The BAHA attract system provides 
good hearing performance in patients 
with a conductive hearing loss or 
single-sided sensorineural deafness, 
with good wearing comfort and minimal 
soft tissue complications  
 
Mojallal et al  Retrospective audiological analysis of bone conduction 
versus round window vibratory stimulation in patients with 
mixed hearing loss  
2015 To compare audiological outcomes in 
patients treated with a BAHA or an active 
middle-ear implant 
Retrospective analysis  Retrospective file review, 
comparative analysis had small 
cohort of patients (six patients in 
each group) 
Nil BAHAs are an effective, simple and 
reliable option for the treatment of 
conductive and mixed hearing loss. 
They are a good option for patients 
unwilling to undergo complex middle 
ear implant surgery 
Lieu et al Management of Children with Unilateral Hearing Loss 2015 To provide an overview of the 
management of children with unilateral 
hearing loss 
Narrative review All includes studies had small 
sample sizes, short follow up times, 
and did not provide long term 
outcome measures  
Nil For children with conductive unilateral 
hearing loss such as from aural atresia 
or ossicular malformation, surgical 
implantation of a bone conduction 
hearing device has been shown to 
improve binaural hearing 
              
et al 
Surgery or implantable hearing devices in children with 
congenital aural atresia: 25 years of our experience  
2015 To compare outcomes of congenital aural 
atresia reconstruction with those of 
bilateral hearing implants (BAHAs, Vibrant 
Soundbridge and Bonebridge) in children 
Retrospective review 
of patients who 
underwent congenital 
aural atresia 
reconstruction. 
Prospective case 
series of patients fitted 
with implants 
Only 8 patients underwent BCHD 
implantation, some patients in the 
BCHD group underwent previous 
atresia surgery, unable to 
differentiate between results of 
BCHD and Vibrant Soundbridge, 
insufficient demographic details for 
implant group 
Nil Implantable hearing devices give 
patients with congenital aural atresia 
better and longer lasting functional 
audiological gain than atresiaplasty  
Doshi et al  Bone anchored hearing aids in children  2015 To provide an overview of bone anchored 
hearing devices in the paediatric 
population 
Narrative review Narrative review of prospective and 
retrospective case series 
Nil Children with unilateral conductive 
hearing loss and unilateral 
sensorineural hearing loss are at a 
higher risk for academic, speech-
language and social–emotional 
difficulties than their normal hearing 
peers. It may be sensible to offer bone 
anchored hearing devices in such 
cases. Bilateral BAHAs have proven to 
be superior to unilateral fitting in adults 
with bilateral hearing loss 
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Coutinho et al  Successful bone-anchored hearing aid implantation in a 
patient with osteogenesis imperfecta 
2015 To report a case of successful BAHA 
implantation in an adult patient with type III 
osteogenesis imperfecta 
Case report Only 1 case, limited follow up of 14 
months 
Nil  A 45 year old man with type II 
osteogenesis imperfecta underwent 
BAHA implantation. The patient had 
mixed hearing loss, with a mild 
sensorineural component in both ears 
and an air–bone gap of 45–50 dB HL. 
Following BAHA implantation, implant 
stability quotient was measured at each 
visit upto 14 months and was found to 
be steady. In selected osteogenesis 
imperfecta cases, osseointegrated 
implants should be considered in the 
management of hearing loss 
Amonoo-Kuofi  Experience of bone-anchored hearing aid implantation in 
children younger than 5 years of age 
2015 To assess outcomes following BAHA 
implantation in children younger than 5 
years of age 
Retrospective chart 
review.  
Retrospective study, only 24 
children, subjective measurement of 
QOL benefit from parents, 
questionnaires filled by parents - 
therefore may reflect their opinions - 
not their child's, recall bias, no 
outcome data published specific to 
each child 
Senior 
surgeons 
performing 
operations, 
only 1 child lost 
to follow up, 
good average 
duration of 
follow up 2.8 
years 
There was a final mean QOL 
improvement following BAHA 
implantation. The BAHA implant 
appears to be of value to children 
under age 5 years. 8 of 24 children 
underwent BAHA implantation under 3 
years of age and whilst no specific 
outcome data for these patients are 
presented, the authors note that mean 
QOL improved 
Riss et al Indication criteria and outcome with the Bonebridge 
transcutaneous bone-conduction implant  
 
2014 To investigate Bonebridge patients 
concerning their functional gain and 
speech perception; to be able to select the 
right patient for this procedure 
 
Retrospective study   Small sample size of 23 patients, 
heterogeneous patient group 
Nil The Bonebridge provides satisfactory 
results concerning functional gain and 
speech perception. It is advisable that 
preoperative bone conduction is within 
45 dB on the ipsilateral ear for 
combined or conductive loss 
 
Marsella et al Sophono in Pediatric Patients: The Experience of an 
Italian Tertiary Care Center 
 
2014 To assess the use of the Sophono device 
in paediatric patients 
Prospective case 
series 
Small sample size of 6 patients, 
subjective QOL measure filled by 
parents  
Prospective 
case series  
Sophono implants can be an effective 
alternative to percutaneous implants in 
patients with bilateral, conductive 
hearing loss  
Al-Qahtani et al External auditory canal atresia: Surgical correction 
compared with bone anchored hearing device 
2014 To evaluate the hearing results, 
complication rate and parental satisfaction 
following BAHA compared to traditional 
surgery in the treatment of external 
auditory canal atresia 
Retrospective study   Retrospective study, telephone 
QOL assessment, non-validated 
QOL measure, heterogeneous 
patients, unequal study groups, 
delay between surgery and 
telephone interview (recall bias)   
Nil  For auditory canal atresia, BAHA 
provides superior hearing results, 
greater parental satisfaction and fewer 
complications than surgery 
Iseri et al A new transcutaneous bone anchored hearing device - the 
Baha Attract System: the first experience in Turkey 
 
2014 To assess the effectiveness of the BAHA 
Attract system  
Prospective case 
series  
Small sample size of 12 patients, 
heterogeneous patients 
Prospective, 
multicentre 
study  
The BAHA attract system is promising 
for patients with conductive or mixed 
hearing loss who are unable to wear 
conventional hearing aid and is 
comparable to percutaneous systems 
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Farnoosh et al Bone-Anchored Hearing Aid vs. Reconstruction of the 
External Auditory Canal in Children and Adolescents with 
Congenital Aural Atresia: A Comparison Study of 
Outcomes 
2014 To compare outcomes in hearing between 
EACR and BAHA in a pediatric population 
with congenital aural atresia 
Retrospective chart 
review  
Retrospective study design, 
subjective QOL questionnaire - 
some completed via telephone, 
recall bias, uneven numbers in each 
group (19 in BAHA group and 49 in 
EACR group), average age was 
significantly different between 
groups, bilateral interventions were 
performed in more children in the 
BAHA group than in the EACR 
group 
Nil 15% of children underwent BAHA for 
unilateral hearing loss. In these 
patients, pure tone average improved 
post BAHA implantation. QOL and 
incidence of surgical complications 
between the two interventions were not 
significantly different. BAHA 
implantation provided a better, more 
reliable audiological outcome than 
EACR 
Dun et al  Bilateral bone conduction devices: improved hearing 
ability in children with bilateral conductive hearing loss 
 
2013 To assess whether children with bilateral 
conductive hearing loss benefit from 
bilateral BAHA fitting 
Retrospective case 
series 
Retrospective, small sample size of 
10 children, different ages of 
patients at implantation, different 
processor used in 1 patient 
Nil  The bone conduction device has better 
hearing outcomes than atresiaplasty in 
patients with congenital aural atresia 
Nicolas et al  Long-term benefit and sound localization in patients with 
single-sided deafness rehabilitated with an 
osseointegrated bone-conduction device 
 
2013 To assess long term satisfaction and 
sound localisation after implantation with 
BAHA in patients with single-sided 
deafness  
Retrospective case 
series 
Retrospective, heterogeneity in 
included patients, subjective QOL 
score, small sample size of 21 
patients  
Nil The BAHA is an effective treatment for 
single sided deafness with 
improvement in speech perception and 
quality of life 
Nadaraja et al  Hearing outcomes of atresia surgery versus 
osseointegrated bone conduction device in patients with 
congenital aural atresia: a systematic review 
2013 To compare hearing outcomes of 
atresiaplasty versus osseointegrated bone 
conduction device (OBCD) in congenital 
aural atresia patients 
Systematic review   All included studies were 
retrospective, considerable 
heterogeneity in included studies  
Systematic 
review 
The bone conduction device has better 
hearing outcomes than atresiaplasty in 
patients with congenital aural atresia 
Hol et al  Comparison Between a New Implantable Transcutaneous 
Bone Conductor and Percutaneous Bone-Conduction 
Hearing Implant 
2013 To compare the percutaneous BAHA 
system with the Sophono Alpha 1 implant  
Retrospective analysis  Small sample size of 6 patients that 
used the BAHA, Retrospective 
study 
Nil All included children had unilateral 
hearing loss (secondary to congenital 
ear canal atresia) and pure tone 
averages for all children improved 
following BAHA implantation. 
Percutaneous BAHA outcomes were 
slightly better compared with Sophonos 
in terms of sound field thresholds, 
speech recognition threshold, and 
speech comprehension at 65 dB. Skin 
reactions were comparable between 
groups  
Doshi et al  Quality-of-Life Outcomes After Bone-Anchored Hearing 
Device Surgery in Children With Single-Sided 
Sensorineural Deafness 
2013 To report outcomes in children with single 
sided sensorineural deafness treated with 
BAHA implantation 
Retrospective case 
review  
Small sample size of 8 children, 
retrospective, subjective 
questionnaire and visual analogue 
scale assessment, questionnaires 
filled by parents - therefore may 
reflect their opinions and not their 
child's, recall bias, children referred 
because of parental concern with 
their child's educational 
development - possibility of 
sele t    b  s due t  “m t   ted” 
parents 
Nil In all but 1 child (7/8 children) with 
single sided sensorineural deafness, 
BAHA implantation resulted in a 
positive Glasgow Children's Benefit 
Inventory score. Mean satisfaction 
score of the BAHA was 9/10. All the 
children had an improved health 
benefit. In addition, when compared to 
the literature concerning adults with 
single sided deafness treated with a 
BAHA, the results in this paper's 
pediatric population are more 
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favourable 
Oliveira et al  Results of the implantation of bone-anchored hearing aids 
in patients with treacher-colllins syndrome 
2013 To present 2 cases of patients with 
Treacher-Collins syndrome who underwent 
implantation of BAHA 
Case report  Only 2 cases, no validated QOL of 
measure, time of follow ups not 
provided  
Nil BAHA resulted in improved audiometric 
results for both patients with Treacher-
Collins syndrome 
Banga et al  Bone-anchored hearing devices in children with unilateral 
conductive hearing loss: a patient-carer perspective 
2013 To evaluate the impact of a BAHA on the 
QOL in children with unilateral conductive 
hearing loss 
Retrospective case 
note analysis  
Small sample size (17 patients), 
retrospective, subjective written and 
visual questionnaires, recall bias, 
large range in ages (6 years to 16 
years), large range between 
patients in terms of age of referral 
and age of BAHA implantation, 
large range in the number of hours 
that children were using the BAHA, 
questionnaires filled by parents - 
therefore may reflect their opinions, 
not their child's 
The single 
sided deafness 
questionnaire 
(SSD) was 
specifically 
designed for 
assessment 
after BAHA 
implantation for 
single sided 
deafness 
Implantation of BAHA resulted in 
improved health status, QOL and 
patient satisfaction in children with 
unilateral hearing loss 
Bento et al  Bone-anchored hearing aid (BAHA): indications, functional 
results, and comparison with reconstructive surgery of the 
ear 
2012 To review the main indications for BAHA, 
and assess the audiological benefits 
compared with other treatment modalities. 
Also to compare the data from the 
literature with the author’s sample of 13 
patients who underwent this procedure 
between 2000 and 2009 
Narrative review  Not a systematic review, included 
studies of limited sample size and 
quality 
Nil  BAHA is a better treatment option than 
reconstructive surgery for patients with 
bilateral deafness 
Marsella et al  Pediatric BAHA in Italy: the "Bambino Gesù" Children's 
Hospital's experience 
2012 T  re  ew the  e tre’s exper e  e w th 
paediatric BAHA from 1995-2009 
Retrospective review  Retrospective study Large sample 
size of 47 
children 
Children with an indication for BAHA 
should be referred to specialised 
centres where they can receive a 
multidisciplinary approach. In such 
settings 1 stage surgery and 
implantation at younger than 5 appears 
safe 
Zeitler et al  Bone-Anchored Implantation for Single-Sided Deafness 
(SSD) in Patients with Less Than Profound Hearing Loss 
2012 To evaluate hearing outcomes in patients 
undergoing BAHA for single sided 
deafness with less than profound hearing 
l ss (≤90 dB HL) 
Retrospective chart 
review. 2 groups 1) 
The study group 
consisted of all SSD 
subjects with less than 
profound hearing loss 
(≤90 dB HL PTA)    
the affected ear 
(residual hearing 
group). The control 
group comprised all 
SSD subjects 
implanted under the 
standard criteria (>90 
dB HL PTA) 
Retrospective, subjective outcome 
measure, different sample sizes 
between the 2 groups (19 in 
residual hearing group and 26 in the 
control group), small sample size, 
variance in inter-subject GHABP 
scores, authors are consultants for 
the main implant company used in 
study 
Presence of a 
control group 
Patients with less than profound 
unilateral SNHL demonstrated 
significant benefit in all measures for 
both fixed and variable signal to noise 
ratio (SNR) testing. These patients also 
reported satisfaction and subjective 
benefit with their BAHA device 
postoperatively. When the residual 
hearing group was compared with the 
control group, no significant objective 
differences were observed for any of 
the listening-in noise conditions 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Janssen et al Bilateral bone-anchored hearing aids for bilateral 
permanent conductive hearing loss: a systematic review 
2012 To compare outcomes following 
implantation of  bilateral BAHAs versus 
unilateral BAHAs in patients with bilateral 
permanent conductive hearing loss  
Systematic review  Systematic review. All 11 included 
studies were of low quality 
(observational studies). Included 
studies consisted of adults and 
children. Bias in selection of 
subjects receiving a second BAHA. 
Different selection criteria between 
studies for bilateral BAHA 
implantation. Limited sample sizes, 
unable to conduct summation 
analysis owing to heterogeneity of 
included studies. Variation between 
included studies on time of follow 
up. Included studies had subjective 
questionnaires 
Systematic 
search. 
Subjects varied 
in age, hearing 
loss etiology, 
and previous 
amplification 
experience - 
therefore 
benefit from 
bilateral BAHA 
does not 
appear to be 
greatly limited 
by any of these 
variables 
Bilateral BAHA provided superior 
audiological benefit compared to 
unilateral BAHA. Bilateral BAHAs also 
resulted in increased patient perceived 
benefit 
Hill et al  Adult bone anchored hearing aid services in the United 
Kingdom: Building a consensus for development  
2012 To gain consensus for BAHA services in 
the UK  
Delphi technique  Poor response rate for initial round, 
increased weight of representation 
from Wrexham and Birmingham 
High level of 
agreement in 
final consensus 
statements 
A consensus of 33 statements was 
validated by this Delphi process. There 
was insufficient agreement on whether 
15 patients per year was the minimum 
number of patients to run a viable 
BAHA service. 10% felt there was no 
viable minimum number of patients 
needed, 2% suggested 5 patients per 
year, 23% suggested a figure of 
between 8 and 12, and 65% felt that 15 
patients per year was an acceptable 
minimum. To be included on the final 
consensus statement there needed to 
be an agreement of more than 75% 
Davies et al  The first reported treatment of Nager syndrome 
associated hearing loss with bone-anchored hearing aids: 
case report 
2012 To report the first case of treatment of 
Nager syndrome associated conductive 
hearing loss with bone- anchored hearing 
aids, in a three-year-old boy.  
 
Case report  Only 1 case. Short 3 months follow 
up 
Nil A three-year-old boy with Nager 
syndrome was successfully treated for 
conductive hearing loss using bilateral 
bone-anchored hearing aids  
Bouhabel et al  Congenital aural atresia: Bone-anchored hearing aid vs. 
external auditory canal reconstruction 
2012 To compare audiological outcomes 
between BAHAs and EACR in children 
with congenital aural atresia 
Retrospective chart 
review. 20 patients 
underwent EACR, 
whereas another 20 
patients were 
implanted with a 
BAHA device 
Retrospective review, small sample 
size (20 patients), large range in 
patient age (3-18), 3 patients had 
concurrent cholesteatoma, different 
preoperative hearing thresholds 
between the 2 groups 
Study 
conducted over 
9 years 
19 of the 20 paediatric patients 
underwent BAHA implantation for 
unilateral hearing loss secondary to 
unilateral congenital aural atresia. This 
resulted in significant improvement in 
audiological outcome. BAHA 
implantation was found to be safe and 
reliable. It also resulted in better 
audiological outcomes than EACR in 
children with congenital aural atresia 
Table 1. Summary and critical assessment of included studies 
QOL quality of life, CSOM chronic suppurative otitis media, BAHA bone anchored hearing aid, EACR External auditory canal reconstruction  
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Initial score based on type of evidence  Quality of methodology  Consistency of results across studies  Directness  Effect size  Overall score  
Low quality (non RCTs) Significant limitations present  Most studies show similar results  Limited generalisability  Limited  Very low quality  
 
 
Table 2. GRADE analysis across the 39 included articles  
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Author Title Year Type of paper Aim of paper Methodology Factors which lower quality Factors which 
raise quality 
Main findings 
Proops Bone anchored hearing 
aids. British Association of 
Otorhinolaryngologists 
Head & Neck Surgeons. 
Statements of clinical 
effectiveness 
1998 Statement paper To provide an overview of BAHAs 
including indications and evidence 
base 
Narrative review/ 
consensus statement 
Statement paper based on expert opinion 
and low quality observational studies  
Nil The BAHA is useful for patients with 
conductive or mixed hearing loss. It is of 
primary benefit to those who are unable to 
wear a conventional hearing aid. BAHAs give 
good audiological and QOL outcomes and 
are low risk. The service is best delivered by  
multidisciplinary teams 
Health Quality 
Ontario 
Bone anchored hearing 
aid. An Evidence-Based 
Analysis 
2002 Health technology 
policy assessment 
To determine the effectiveness and 
cost-effectiveness of BAHAs in 
improving the hearing of people 
with conductive or mixed hearing 
loss 
Descriptive synthesis of 
findings from 36 
research articles 
published between 
January 1990 and May 
2002 
All evidence was derived from observational 
studies (case series and non-randomised 
comparative studies). Included studies had 
small sample sizes ranging from 30-188 
patients. There was heterogeneity amongst 
included studies. Many included studies 
focused on subjective patient satisfaction 
data 
The majority of 
included 
studies had 
follow-up 
periods of eight 
years or longer 
BAHA implantation is safe. The need for 
BAHA is not dependent on age. Objective 
and subjective measures demonstrated 
significantly improved hearing following 
BAHA implantation. Recipients of BAHAs 
should be at least 5 years old. The benefits 
of paediatric BAHA appear to outweigh the 
disadvantages. No literature on cost-
effectiveness was available 
Macnamara et 
al 
The bone anchored 
hearing aid (BAHA) in 
chronic suppurative otitis 
media (CSOM) 
1996 Journal article To assess the outcome of BAHAs 
in patients with CSOM  
Retrospective case 
review 
Retrospective study, large range of follow-up 
(1 month to 7 years), short mean follow-up 
of 24 months, some patients received other 
previous treatments which may be a 
confounding factor, subjective questionnaire, 
risk of recall bias 
Good sample 
size (69 
patients) 
CSOM is an indication for BAHAs. In 84% of 
cases, patients had significantly reduced 
discharge. The majority of patients wore their 
BAHA for more than eight hours per day and 
58 per cent were more satisfied with their 
BAHA than their previous aid 
Wazen et al Results of the bone-
anchored hearing aid in 
unilateral hearing loss 
2001 Journal article To evaluate the effectiveness of the 
BAHA in patients with unilateral 
conductive or mixed hearing losses 
Prospective case series Small sample size of 9 patients. Short follow 
up 
Nil BAHA was successful in improving binaural 
hearing in patients with unilateral conductive 
or mixed hearing loss. BAHA is a safe 
intervention 
The National 
Deaf 
Children's 
Society 
Quality Standards in Bone 
Anchored Hearing Aids for 
Children and Young 
People 
2010 Quality standards 
guidelines 
To provide guidelines for 
professionals working with deaf 
children and young people 
Narrative review No published methodology on how this 
guidance was produced, majority of included 
studies were observational studies with 
limited sample sizes and follow-up times 
Nil BAHAs are an effective option for children 
with chronic middle or outer ear infection, 
children with congenital abnormality of the 
ears, children with severe-profound unilateral 
hearing loss. BAHAs should be offered as 
soon as clinically appropriate to help develop 
speech and communication ability. This will 
be when the multidisciplinary team and the 
 h ld’s p re ts    s der the  h ld t  be an 
appropriate candidate.  
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Gillett et al Bone-anchored hearing  
aids: results of the first 
eight years of a program 
in a district general 
hospital, assessed by the 
Glasgow benefit inventory 
2006 Journal article To report the clinical results of a 
BAHA programme in a district 
general hospital 
Retrospective 
questionnaire study 
Retrospective study, subjective 
questionnaire, poor response rate for 
questionnaire (69%) 
Good sample 
size (41 
patients); long 
period of data 
collection 
(1994-2003) 
BAHA implantation significantly improved 
QOL. The BAHA is a safe, and effective 
treatment for selected patients. A successful 
BAHA programme can be run in a district 
general hospital. 
Burrell et al  The bone anchored 
hearing aid: the third 
option for otosclerosis. 
1996 Journal article To present their experiece of BAHA 
for patients with otosclerosis 
Retrospective case 
review 
Retrospective study, small sample size (19 
patients), full set of post operative data only 
available for 9 patients, subjective outcome 
measures, discrepancy between objective 
audiological assessment and patients' 
subjective responses 
Nil BAHA results in audiological improvements 
in patients with bilateral otosclerosis. BAHAs 
may be another option for those 
unwilling/unable to have stapedectomy or 
hearing aid 
 
Personal 
communication 
Personal communication. 
Dr David Selvdurai 
Consultant Ear Nose and 
Throat Surgeon, St 
Ge rge’s H sp t l, 
Tooting, London 
Unknown Personal 
communication 
N/A N/A Personal communication, no transcript Nil Nil 
NHS 
Specialised 
services 
Specialised services 
national definitions set 
(2nd edition) 
2009 Definition set To identify an activity that should 
be regarded as specialised 
services 
Narrative review Included articles were observational studies 
with small sample sizes and short patient 
follow up. Some studies had subjective 
patient outcome measures 
Nil Suitable candidates for BAHA are those who 
have a conductive hearing loss, mixed 
hearing loss or single sided deafness and 
are unable to wear a conventional aid. They 
can also be suitable for atretic ears, chronic 
suppurative otitis media. The service 
requires a multidisciplinary team 
Quebec 
AETMIS 
Bone-anchored hearing 
aids. Summary. Agence 
d’e  lu t    des 
technologies et des 
m des d’  ter e t    e  
sant  
2006 Technology 
assessment 
This is an assessment of BAHAs by 
AETMIS (Age  e d’   lu t    des 
te h  l g es et des m des 
d’  ter e t    e  s  te  ) 
This assessment of 
BAHAs by AETMIS 
used the Health Quality 
Ontario review as a 
starting point. They 
then conducted a 
literature review 
between 2002 and 
2005 
AETMIS acknowledge that their assessment 
is based on limited evidence. Their 
document mainly used evidence gained from 
the 2002 Health Quality Ontario Review - 
where all included studies were of low 
quality evidence (case series or non 
randomised comparator studies). In their 
own literature review, covering the period 
from 2002 to 2005, none of the included 
studies were randomised controlled trials. 
They were observational studies with limited 
sample sizes 
The majority of 
the studies 
have follow-up 
periods of eight 
years or longer 
BAHAs significantly improved users' hearing 
thresholds and speech. BAHAs also led to 
subjective improvements in QOL and were 
deemed safe. BAHAs should be implanted 
following multidisciplinary team assessment. 
Centres performing BAHAs should treat at 
least 15 cases per year. Children should be 
aged 5 or over 
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Table 3. Summary and critical assessment of the evidence base informing the 2013 BAHA Commissioning Policy  
QOL quality of life, CSOM chronic suppurative otitis media, BAHA bone anchored hearing aid, ICER incremental cost effectiveness ratio, QALY Quality adjusted life year 
 
Monksfield et 
al 
Cost-effectiveness 
Analysis of the Bone-
Anchored Hearing Device 
2011 Journal article To establish the cost-effectiveness 
of BAHAs 
A prospective cohort 
case-control analysis 
Costs for treatment were obtained from the 
Birmingham BAHA program and may not be 
nationally representative. Self-selection of 
patients who had been invited to participate 
may be a source of bias. Subjects acted as 
their own control rather than a true case-
control study. There were limitations in cost 
collection data: data used were the billing 
rates to the primary care trust funding the 
BAHA. Detailed costs were not collected. 
These included: assessment, operation, 
post operative care, adverse events, primary 
care costs, non medical costs. The 
opportunity cost of a contralateral routing of 
signal aid was not taken into account for 
patients in which it may have been 
appropriate. Nineteen patients did not 
complete the full study which may affect 
utility results 
Use of the 
Health Utility 
Index (HUI) as 
a measure of 
heath utility 
because the 
HUI includes 
questions on 
hearing. Good 
sample size of 
89 patients for 
data analysis. 
The BAHA is likely to be cost effective. The 
ICER was £17,610 per QALY. At a cost-
effectiveness threshold of £20,000 per 
QALY, there is a 56% probability that a 
BAHA is cost-effective and 69% probability if 
the threshold is £30,000 per QALY. 
House et al Bone-anchored hearing 
aids: incidence and 
management of 
postoperative 
complications 
2007 Journal article To investigate the complications of 
BAHA implantation 
Retrospective case 
review 
Retrospective study. Subjective 
questionnaire. Poor response rate for the 
questionnaire (69%) 
Good sample 
size (149 
patients) 
Complications of BAHA are low in incidence 
and severity. The most common 
complication was skin overgrowing the 
BAHA abutment (7.4%) 
ARIF Aggressive Research 
Intelligence Facility. Bone 
anchored hearing aids 
(bilateral): conductive 
hearing loss deafness 
2005 Advice on the 
evidence on the 
clinical and cost-
effectiveness of 
BAHAs 
To provide advice on the clinical 
and cost effectiveness of bilateral 
BAHAs in comparison with 
unilateral BAHAs 
ARIF is a specialist unit 
based at the University 
of Birmingham. It 
incorporates research 
findings in order to help 
advise on problems 
submitted to ARIF 
All evidence was derived from five small 
case series with sample sizes ranging from 
3 to 25. No systematic reviews were 
identified. With no control group in the 
included studies, they may be a tendency for 
reporting bias and confounding factors 
Nil The clinical effectiveness of bilateral BAHAs 
is neither fully supported nor refuted 
Personal 
communication 
Personal Communication, 
Dr Elwina Timehin, Mr 
David Selvadurai, BAHA 
Programme, St Georges 
Healthcare NHS Trust 
Unknown Personal 
communication 
To gain opinions from stakeholders Personal 
communication 
Personal communication Nil “P t e ts w th u  l ter l se s r  eur l 
deafness do benefit from using the device. At 
present we give them a trial of a CROS 
(Contralateral Routing of Sound) aid when 
assessing their suitability for the device. In 
general if they benefit from its use then they 
def   tely be ef t fr m us  g the BAHA”   d 
“The t t l  umber  f p t e ts  s sm ll, 
perhaps only 2-3 per year across all our 
PCTs” 
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Initial score based on type of evidence  Quality of methodology  Consistency of results across studies  Directness  Effect size  Overall score  
Low quality (non RCTs) Significant limitations present  Most studies show similar results  Limited generalisability  Limited  Very low quality  
 
 
Table 4. GRADE analysis across studies informing the 2013 NHS commissioning policy  
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